AI Agents for Regulated Life Sciences — Built to Stand Up to an Inspector.
GxP Agents builds pre-validated AI agents across Quality, Regulatory Affairs, Clinical, Manufacturing, and Safety. Agents draft, verify, and escalate alongside your existing QMS, RIM, and EBR—while a qualified human signs every GxP decision.
- Batch review effort saved
- 50–80%
- Faster deviation triage
- 65%
- Single-domain pilot
- 4–8 wks
- Human-signed GxP decisions
- 100%
Connected: Veeva Vault QMS · Stage: Review by Exception
Bioreactor B-04 dissolved oxygen excursion (+4.2% for 14 min)
Ingested shift log, SCADA telemetry, and 50,000+ historical site deviations.
Historical pattern & recurrence check
Matched 3 prior sensor drift events on Suite 2 probes; zero batch potency impact.
SOP-QA-014 §4.20.8sSeverity & product-impact classification
Classified Minor Deviation — Critical Process Parameter remained within validated proven acceptable range.
ICH Q10 / 21 CFR 211.1921.1sDrafted investigation scope & CAPA check
Pre-populated root-cause tree and optical probe calibration verification work order.
SOP-METRO-0091.4s
Route as Minor Deviation to Biologics QA Lead; release hold not required pending probe calibration check.
Accountable Role: Director, Site Quality Operations · Classification & Investigation Scope Approval
Connected: MasterControl / SAP EBR · Stage: Review by Exception
154-page Electronic Batch Record · Sterile Fill-Finish Lot 904A
Verified 1,420 inline IPC data points, 68 operator e-signatures, and environmental monitoring logs.
Specification & IPC range verification
1,419/1,420 parameters inside target window; flagged 1 filter differential pressure spike for QA focus.
MBR-FF-204 Rev 111.6sSignature & training matrix cross-check
Confirmed all 68 Part 11 signatures valid and operator aseptic qualifications current in LMS.
21 CFR 11.50 / 211.250.9sGenerated 2-page QA Exception Dossier
Compressed 154 routine pages into an audit-linked exception summary citing page 87 step 14.3.
EU GMP Annex 111.2s
Auto-verified 99.3% of mechanical checks; escalate single filter pressure excursion to Qualified Person.
Accountable Role: QA Batch Disposition Lead / QP · Exception Review & Lot Release Sign-Off
Connected: Veeva Vault RIM · Stage: Sampled Review
Module 3.2.P Stability & Analytical Validation Cross-Check
Cross-referenced 28 stability tables, CoAs, and latest FDA/ICH analytical validation guidance.
Source-to-submission data reconciliation
Verified 100% numeric parity between LIMS 12-month stability pulls and Module 3.2.P.8 tables.
ICH M4Q(R1) / Q1A(R2)1.9sGuidance & precedent gap scan
Flagged missing degradation Mass Balance justification requested in recent FDA Type B feedback.
ICH Q2(R2) §3.11.3sDrafted Module 2.3 Quality Overall Summary
Generated hyperlinked narrative with inline source anchors to validated LIMS study reports.
FDA eCTD v4.02.1s
Insert drafted Mass Balance justification in §3.2.P.5.3 before final Regulatory Affairs sign-off.
Accountable Role: VP, Global Regulatory CMC · Submission Content Verification
Connected: TrackWise / OneTrust · Stage: Close Review
Cloud Bio-LIMS Supplier · SOC 2 Type II Renewal & Annex 11 Audit
Parsed 118-page SOC 2 report, penetration test summary, and Part 11 tenant configuration.
Control exception & subservice mapping
Detected 1 bridge-letter gap on AWS EU-Central backup key rotation; mapped to GxP data integrity risk.
GAMP 5 2nd Ed. App D111.5sPart 11 & GDPR residency verification
Verified immutable audit trail retention (15 yrs) and Frankfurt EU data residency lock.
21 CFR Part 11 / GDPR Art 280.7sDrafted Vendor Risk Remediation Plan
Generated supplier CAPA request with 30-day key-rotation evidence milestone.
SOP-SEC-TPRM-041.0s
Approve Conditional Qualification subject to 30-day KMS key-rotation attestation.
Accountable Role: CISO & Head of IT CSV · Supplier Qualification Risk Acceptance
Vetter-Ready Assurance
Engineered for CSV, QA & Security Review
21 CFR Part 11
E-Signatures & Audit Trails
GAMP 5 / CSA
IQ · OQ · PQ Validation Package
SOC 2 Type II
Annual Independent Audit
ISO 27001
Certified ISMS Controls
EU AI Act & Annex 11
High-Risk Human Oversight
Enhances Your Validated Systems of Record — Never Replaces Them
Pre-built connectors and REST APIs maintain end-to-end data integrity and audit trails across your existing GxP stack.
Veeva Vault
QMS · RIM · eTMF
TrackWise Digital
Enterprise QMS
MasterControl
Quality & EBR
Medidata
Clinical Cloud
Oracle Argus
Pharmacovigilance
SAP S/4HANA
ERP & Batch Release
ETQ Reliance
Quality Management
AWS & Azure VPC
US & EU Residency
Purpose-Built Multi-Agent Suites Across Every GxP Function
Select a domain to inspect its orchestrator topology, video briefing, and Assistive → Generative → Predictive progression.
Executive Video Briefing
AI Agents in Quality
Quality
Quality functions are increasingly expected to operate as the backbone of regulatory confidence, operational continuity, and enterprise risk management. However, most Quality organizations still rely on manual coordination, document-heavy processes, and institutional knowledge to manage deviations, CAPAs, supplier quality, and inspection readiness.
30-50%
reduction in deviation triage and investigation cycle time through automated classification, routing, and contextual analysis
25-40%
reduction in CAPA backlog driven by improved prioritization and earlier identification of systemic issues
Supervisory Inspection AI Agent
Quality Systems & QMS Agent
Specialized agent for quality systems.
Manufacturing & CMC Agent
Specialized for manufacturing compliance.
Data Integrity / CSV Agent
Specialized for data integrity.
Clinical & TMF Agent
Specialized for clinical trial files.
Deviation Management
CAPA Management
Executive Video Briefing
AI Agents in Regulatory Affairs
Regulatory Affairs
Regulatory organizations face increasing complexity: more markets, faster product change cycles, higher post-approval obligations, and rising expectations for traceability and data integrity. Despite these pressures, many regulatory processes remain fragmented, document-centric, and manually reconciled—leading to slower submissions, increased HA questions, and elevated compliance risk.
20-35%
reduction in submission readiness timelines driven by automated QC and content assembly
30-50%
improvement in commitment tracking accuracy and on-time completion rates
Supervisory Labeling Orchestrator Agent
Concept Mapping & Delta Agent
Compares versions, extracts deltas, and maps changes to labeling taxonomies.
Market Impact Agent
Identifies impacted markets, languages, and packs/artwork.
Evidence & Justification Agent
Retrieves supporting evidence and prepares rationale packets.
Response Drafting Agent
Drafts labeling language using approved patterns and controlled vocabularies.
Submission Readiness & QC
Labeling Management
Executive Video Briefing
AI Agents in Clinical Development & Operations
Clinical Development & Operations
Clinical operations are under constant pressure to accelerate timelines while improving oversight quality across studies, sites, and vendors. Despite digital platforms, many critical tasks remain manual, reactive, and retrospective—especially TMF oversight, inspection readiness, protocol interpretation, and vendor performance management.
30-50%
reduction in manual TMF QC effort, allowing teams to focus on remediation rather than document chasing
20-30%
faster study startup timelines driven by automation of readiness artifacts and protocol interpretation
TMF Orchestrator Agent
Document Classification & Metadata Agent
Classifies artifacts (ICFs, IBs, monitoring reports) and validates metadata quality, filing location, and version consistency.
Completeness & Expectedness Agent
Determines expected artifacts by study phase, country, site, and vendor model.
Quality Scoring & Findings Agent
Evaluates basic quality signals (signatures, dates, completeness markers) and generates QC summaries.
Inspection Response Agent
When inspection requests arrive, retrieves artifacts, drafts narratives, and assembles evidence packets.
Study Startup Automation
Protocol Interpretation & SOA Generation
Executive Video Briefing
AI Agents in Manufacturing & Supply Chain
Manufacturing & Supply Chain
Manufacturing and supply chain functions sit at the point where compliance, product availability, and revenue converge. Delays or errors in these areas have immediate downstream impact—missed patient supply, delayed launches, inventory write-offs, and regulatory risk.
50-80%
reduction in batch record review effort through exception-based review models
20-40%
reduction in unplanned equipment downtime through predictive maintenance and early intervention
Batch Review Orchestrator Agent
Data Ingestion & Normalization Agent
Ingests batch data from MES, LIMS, and ancillary systems.
Rules & Specification Evaluation Agent
Applies approved business rules, specifications, and acceptance criteria.
Anomaly Detection & Pattern Analysis Agent
Uses historical batch data to identify statistical outliers, drift, or unusual combinations.
Exception Summarization Agent
Generates concise, structured summaries of flagged exceptions.
Batch Record Review by Exception
Material Release Automation
Executive Video Briefing
AI Agents in Safety & Pharmacovigilance
Safety & Pharmacovigilance
Safety organizations face a structural challenge: case volumes are growing 8-12% annually, regulatory timelines are compressing, and qualified PV professionals remain scarce. Traditional responses—more headcount, more outsourcing—scale cost linearly with volume.
50-70%
reduction in narrative drafting time through AI-assisted generation and template reuse
40%+
improved case throughput without added headcount, preserving medical judgment
Case Orchestrator Agent
Data Ingestion & Entity Extraction Agent
Ingests source documents and extracts key entities (patient, drug, event, reporter).
Timeline & Context Reconstruction Agent
Constructs chronological narratives from disparate data sources.
Narrative Drafting Agent
Generates structured case narratives using templates and approved language.
Compliance & Readiness Agent
Checks completeness for reporting requirements and tracks expedited reporting timelines.
Automated Case Intake
AI-Assisted Narrative Generation
Executive Video Briefing
AI Agents in Medical Affairs
Medical Affairs
Medical Affairs faces compounding pressure: promotional review volumes have grown 15-25% annually, MLR cycle times average 4-6 weeks, and content rework rates often exceed 30%. Meanwhile, field teams generate insights that remain trapped in unstructured notes and CRM fields.
25-35%
reduction in MLR review cycle time, particularly during peak submission periods
20-30%
reduction in content rework rates driven by earlier risk identification
MLR Orchestrator Agent
Claims & Content Analysis Agent
Identifies scientific and promotional claims, maps to approved indications and labels.
Reference Validation Agent
Verifies that cited references are current, approved, and accurately represented.
Risk & Consistency Assessment Agent
Compares content against prior approved materials and highlights inconsistencies.
Reviewer Support & Drafting Agent
Generates draft review comments or suggested edits with rationale tied to guidance.
MLR Review Automation
Medical Inquiry Management
Executive Video Briefing
AI Agents in Cybersecurity & Third-Party Risk Management
Cybersecurity & Third-Party Risk Management
Cybersecurity and third-party risk are no longer IT-only concerns. In life sciences organizations, they are now core GxP, data integrity, and inspection risks.
40-60%
reduction in manual vendor assessment effort, particularly for low- and medium-risk vendors
70%+
earlier identification of vendor risk signals, often weeks or months before traditional reviews
Vendor Risk Orchestrator Agent
Documentation & Control Review Agent
Ingests SOC reports, ISO certifications, questionnaires, and policies.
Continuous Signal Monitoring Agent
Monitors security incidents, breach notifications, threat intelligence feeds, and operational stress indicators.
Risk Scoring & Prioritization Agent
Aggregates inherent risk, control maturity, and live signals to produce dynamic vendor risk scores.
Audit & Inspection Support Agent
Assembles evidence packets for audits and inspections, drafts oversight narratives.
Vendor Onboarding Automation
Continuous Vendor Risk Monitoring
Executive Video Briefing
AI Agents in Corporate & Enabling Functions
Corporate & Enabling Functions
Corporate and enabling functions—Finance, HR, Procurement, Legal, and IT—are often viewed as back-office support. In regulated life sciences environments, however, these functions play a direct role in compliance, inspection readiness, and operational continuity.
30-50%
faster incident resolution in ITSM, reducing disruption to GxP systems
40%+
more predictable financial close cycles with fewer late reconciliations and audit findings
ITSM Orchestrator Agent
Classification & Triage Agent
Analyzes incoming tickets using NLP, identifies impacted systems and risk level.
Resolution & Knowledge Agent
Retrieves relevant knowledge articles, past incidents, and fixes.
Change Impact & Risk Agent
Assesses potential impact of changes on GxP systems and processes.
Service Risk Prediction Agent
Analyzes historical trends to predict incident spikes or recurring failures.
HR Operations Automation
Finance Close & Controls Automation
Regulated Governance Architecture
Trust Is Earned in Stages. The Human Signature Never Moves.
Unsupervised black-box autonomy fails regulatory inspections. GxP Agents scales efficiency by narrowing mechanical review burden as validation evidence accumulates—while keeping a human signature locked at every GxP decision gate.
Close Review
Where every newly deployed agent begins. It classifies, cross-checks, and drafts with inline SOP citations while a qualified specialist inspects every output prior to use.
Sampled Review
Once validated against baseline volume and PQ acceptance criteria, reviewers audit a statistical sample alongside every low-confidence or novel edge case.
Review by Exception
Proven agents verify routine mechanical checks automatically and surface concise exception dossiers—freeing QA and Regulatory teams to focus on judgment.
Human Signs the GxP Decision
At every maturity tier, an authorized person reviews the reasoning chain and applies a compliant electronic signature. Overrides are logged and feed continuous validation.
- WHO
- Agent ID + Accountable Human Signer
- WHAT
- Input, Prompt Version, Output & Diff
- WHEN
- UTC Synchronized Tamper-Proof Timestamp
- WHY
- SOP Citation, Confidence & Override Reason
Move Fast and Safely in the Age of AI: Meet Your New Human-in-the-Loop Agent Team.
Legacy thinking says you have to choose between moving slowly behind manual validation and release binders—or moving fast with unvalidated AI. With GxP Agents and our strategic partner USDM Life Sciences, your people gain a safe, inspection-ready team of AI agents working directly with your existing systems, data, and platform today.
Legacy Validation vs. HITL Agent Teams
Why HITL Agent Teams Win
Safe on paper, but 30–45 day deviation cycles, 18-hour manual batch reviews, and months of manual CSV slow down product release.
Fast chat output, but fails 21 CFR Part 11 (§ 11.50), EU GMP Annex 22 deterministic boundaries, and ALCOA+ provenance.
60–80% faster validation and release management, zero compliance risk, human e-signature on every GxP decision, and live in 4–8 weeks.
Zero Rip-and-Replace
Agents sit cleanly across Veeva Vault, TrackWise, MasterControl, SAP ERP, LIMS, MES, and Oracle Argus via read-scoped connectors.
Closed-Boundary ALCOA+ Integrity
Deployed inside your AWS/Azure VPC or on-premises boundary with AES-256 encryption and zero public model training on your GxP records.
Elevated to Command & Sign-Off
Specialists stop copy-pasting across systems and focus on high-judgment exception review and 21 CFR § 11.50 electronic signatures.
Validated by Regulated AI Experts
Sponsored in strategic partnership with USDM Life Sciences—bringing 25+ years of daily GAMP 5, CSA, and inspection-readiness execution.
Measured Production Evidence
Verified Outcomes from Regulated Deployments
Four anonymized pharma, biotech, and diagnostics client deployments (under NDA), paired with observed cross-deployment impact ranges.
50–80%
Reduction in batch record review effort
Exception-based EBR verification across manufacturing QA
40–60%
Faster inspection response times
Always-on traceability & audit readiness retrieval
30–50%
Shorter deviation triage cycle time
Automated classification & historical recurrence matching
25–35%
Shorter MLR review cycle time
Pre-screened promotional claims & reference verification
Top 10 Pharma Reduces Deviation Triage Time by 65%
AI-powered deviation classification transformed a drowning quality team into proactive risk managers.
- 65% reduction in triage time — from 5 days to 1.8 days average
- 40% fewer misclassified deviations — AI caught patterns humans missed
Biotech Startup Completes FDA IND Submission 3 Months Ahead of Schedule
AI-assisted eCTD submission assembly and regulatory intelligence turned an 18-month timeline into 15.
- 15-month completion — 3 months ahead of the original 18-month IND target
- Cleared initial 30-day FDA IND review cycle with zero clinical hold comments
Global Diagnostics Company Cuts Cybersecurity Vendor Risk Assessment from 6 Weeks to 3 Days
AI-powered vendor risk scoring turned an annual compliance exercise into continuous intelligence.
- 95% reduction in assessment time — from 6 weeks to 3 days per vendor
- Real-time risk dashboards replaced annual point-in-time snapshots
Mid-Size Pharma Automates 80% of Batch Record Review
AI-assisted review freed QA to focus on exceptions, not paperwork — and caught errors humans missed.
- 80% of batch records auto-verified with exception-based human review
- 4-hour review cycle time (down from 18 hours) — 78% reduction
Ready-to-Deploy Workflow Architectures
6 Commercial Workflow Blueprints
Deviation & CAPA Triage
Automate GxP deviation triage, 24-month historical recurrence clustering, and CAPA root-cause drafting under 21 CFR 211.192 and Part 11.
Batch Record Review (EBR)
Accelerate pharmaceutical batch release with AI batch record review-by-exception across MES, LIMS, and ERP under 21 CFR 211.188 and EU Annex 11.
eCTD Submission Readiness
Automate IND/NDA/BLA eCTD Module 2 & Module 3 CMC cross-checking, source traceability, and regulatory intelligence under ICH M4 and 21 CFR Part 11.
PV & ICSR Case Automation
Automate adverse event ICSR intake, MedDRA v27 coding, seriousness triage, and case narratives under 21 CFR 314.80, EU GVP Module VI, and ICH E2B(R3).
GxP Vendor & Cyber Risk (TPRM)
Automate SaaS/cloud vendor GxP qualification, SOC 2 / ISO 27001 evidence parsing, and continuous cyber threat monitoring under 21 CFR Part 11 and NIS2.
FDA & EMA Inspection Readiness
Maintain continuous FDA 483 and EMA inspection readiness with AI audit storyboards, CAPA effectiveness verification, and training matrix reconciliation.
From First Call to Validated Production in 4–8 Weeks
Horizontal AI vendors leave your QA team holding the validation bag. Pure consultancies build one-off custom code from scratch. GxP Agents delivers ready-built domain agent suites with native QMS/LIMS/RIM connectors, pre-authored IQ/OQ/PQ protocols, and mandatory 21 CFR Part 11 human signature gates out of the box.
Assistive · Generative · Predictive
GxP Agents Orchestration Engine
Independent regulated AI platform. Sponsored in strategic validation partnership with USDM Life Sciences.
- PHASE 01Week 1–2
Discovery & Workflow Selection
Prioritize high-ROI bottlenecks (deviation triage, batch review, eCTD assembly, TPRM) and align Part 11, CSA, and system connector requirements.
- PHASE 024–8 Weeks
Single-Domain Validated Pilot
Configure agents to your SOPs alongside Veeva, TrackWise, SAP, or Medidata under Close Review—proving cycle-time and accuracy gains on real records.
- PHASE 03Included
Complete IQ / OQ / PQ Package
Full requirements traceability matrix, GAMP 5 / CSA test scripts, validation summary report, and optional independent validation sign-off with sponsor partner USDM Life Sciences.
- PHASE 043–6 Months
Phased Enterprise Expansion
Graduate proven agents to Sampled or Exception Review and expand across Quality, Regulatory, Clinical, Manufacturing, and Safety.
See GxP Agents Working on Your Regulated Workflows
Schedule a working session with our domain and CSV specialists—including a live walkthrough of the Deviation Assistant, Quality Agent Suite, and IQ/OQ/PQ validation package.